Efficacy of a Novel Peptide Immunotherapy for Rheumatoid Arthritis

新型肽免疫疗法治疗类风湿关节炎的功效

• 批准号: 475862
• 负责人: Toor Jaspreet
• 金额: $ 7.65万
• 依托单位: University of Western Ontario
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-11-01 至 2025-11-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=475862&lang=en
• 关键词: Autoantibodies; Autoimmunity; Behavioural Testing; Flow Cytometry; Histopathology; Immune Tolerance; Medical Imaging Techniques; Mouse Models Of Human Disease; Rheumatoid Arthritis; Therapeutics/Immunotherapy

During my PhD, I will test a new treatment created by our lab for Rheumatoid Arthritis (RA), a common chronic disease for which there is no cure nor disease-specific treatment. RA is an autoimmune disease where a problem with the immune system-our body's

在攻读博士学位期间，我将测试我们实验室针对类风湿性关节炎 (RA) 开发的一种新疗法，这是一种常见的慢性疾病，无法治愈，也没有针对特定疾病的治疗方法。 RA 是一种自身免疫性疾病，是由于我们身体的免疫系统出现问题而导致的。